NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd, announced today that the European …
![NS Pharma NS-229: Orphan Drug Designation for EGPA Treatment](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-julie-viken-593451-1.jpg?resize=760%2C427&ssl=1)
![NS Pharma NS-229: Orphan Drug Designation for EGPA Treatment](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-julie-viken-593451-1.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd, announced today that the European …
PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody …